Erlotinib Induced Skin Rash Spares Skin in Previous Radiotherapy Field
Author:
Affiliation:
1. Royal Sussex County Hospital, Brighton and Sussex University Hospital National Health Service Trust, Brighton, United Kingdom
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.1631
Reference11 articles.
1. ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial
2. Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial
3. Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies
4. Uncommon Presentations of Hodgkin's Disease
5. In Reply:
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes;Journal of Clinical Investigation;2020-02-04
2. Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy;Science Translational Medicine;2019-12-11
3. Erythema multiforme occurring during concomitant chemoradiation for anal canal cancer: a case report;European Journal of Medical Case Reports;2019
4. A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients;The AAPS Journal;2015-08-19
5. Erythema Multiforme, Stevens Johnson Syndrome, and Toxic Epidermal Necrolysis Syndrome in Patients Undergoing Radiation Therapy;American Journal of Clinical Oncology;2014-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3